Abbott India Limited vs Wipro Limited
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Abbott India Limited (Pharmaceuticals) and Wipro Limited (Information technology services and consulting) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, Wipro Limited leads on Revenue (approx.).
Wipro Limited leads on Revenue (approx.).
Choose Abbott India if you want exposure to branded pharmaceuticals in India, supported by strong parentage, recognized therapy brands, and an established doctor and pharmacy network. Choose Wipro if you prefer a global IT services and consulting business with a broad portfolio across cloud, cybersecurity, AI, consulting, and outsourcing. The right choice depends on whether the buyer prioritizes domestic pharma brand strength and higher-margin formulations or enterprise technology services with global delivery, while accepting each company’s sector-specific risks.
Grounded in the verified figures and SWOT shown — guidance, not investment advice.
Head-to-head highlights
| Metric | Abbott India Limited | Wipro Limited | Basis |
|---|---|---|---|
| Revenue (approx.) | INR 5,800-6,200 crore | About US$10.8 billion | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Abbott India Limited
Pharmaceuticals · India
Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories. It markets branded prescription and over-the-counter healthcare products across therapeutic areas such as gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
Verified financials
No source-verified financials available.
Strengths
- Strong parentage from Abbott Laboratories
- Recognized brands in chronic and specialty therapeutic areas
- Established doctor and pharmacy distribution network
- Focus on higher-margin branded formulations
Weaknesses
- High dependence on the Indian domestic pharmaceutical market
- Limited scale compared with India's largest pharma companies
- Exposure to price controls on essential medicines
- Relatively concentrated portfolio in select therapies
Opportunities
- Growth in chronic disease treatment demand in India
- Expansion in women's health, gastroenterology, and metabolic care
- Digital engagement with physicians and patients
- Leveraging Abbott's global portfolio for India-specific launches
Threats
- Intense competition from Indian generic and branded-generic companies
- Regulatory pricing pressure from India's drug price control regime
- Changes in physician prescribing behavior
- Supply chain and input cost volatility
Wipro Limited
Information technology services and consulting · India
Wipro Limited is a global technology services and consulting company headquartered in India. It provides digital transformation, cloud, cybersecurity, engineering, data analytics, AI, and business process services to enterprises across multiple industries.
Verified financials
No source-verified financials available.
Strengths
- Established global delivery footprint
- Broad portfolio across cloud, cybersecurity, AI, consulting, and outsourcing
- Strong presence in enterprise IT services
- Long operating history and recognized brand in Indian IT services
Weaknesses
- Growth has at times lagged some larger Indian IT peers
- Highly exposed to discretionary enterprise technology spending cycles
- Margin pressure from wage inflation and pricing competition
- Complex organizational transformation requirements
Opportunities
- Rising enterprise adoption of generative AI and automation
- Cloud modernization and cybersecurity demand
- Expansion in industry-specific consulting and platform-led services
- Growth in managed services and cost-optimization outsourcing
Threats
- Intense competition from global IT services and consulting firms
- Macroeconomic slowdowns affecting client technology budgets
- Currency volatility between revenue and cost bases
- Talent retention and reskilling challenges
Frequently asked
Answered from source-verified figures on this page.
Abbott India Limited vs Wipro Limited: which company leads overall?
Wipro Limited leads on Revenue (approx.).
Related market reports
Deep-dive intelligence on the markets these companies compete in.
India Digital Payments Market — Intelligence Report
Embedded Finance & Banking-as-a-Service (BaaS) Market — Intelligence Report
Global Digital Payments & Real-Time Rails Market — Intelligence Report
India Protein Industry Outlook — Intelligence Report
AI Analyst
Insights and answers generated live from Abbott India Limited vs Wipro Limited's verified data. Modeled estimates — not investment advice.
- Abbott India Limited operates in India’s pharmaceuticals industry as a listed subsidiary of Abbott Laboratories.
- Abbott India markets branded prescription and over-the-counter healthcare products across areas including gastroenterology, women’s health, metabolic disorders, CNS, pain management, and vaccines.
- Wipro Limited is headquartered in India and provides global technology services and consulting across digital transformation, cloud, cybersecurity, engineering, data analytics, AI, and business process services.
- Notable point: The two companies are both India-based but operate in distinct sectors, with Abbott India focused on healthcare products and Wipro focused on enterprise technology services.